NETEC Resource Library

Testing COVID-19 therapies to prevent progression of mild disease

Item

Click for External Resource*


Click to read full article*


*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.


Item Type

Publication

Terms of Use

By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.

Share this page:

Was this resource helpful?


Title

Testing COVID-19 therapies to prevent progression of mild disease

Description

A randomised controlled trial found no significant benefit of lopinavir-ritonavir over placebo in patients with severe corona-virus disease 2019 (COVID-19).

Date

2020-05-06

Citation

Lipsitch, Marc, Stanley Perlman, and Matthew K. Waldor. 2020. "Testing COVID-19 therapies to prevent progression of mild disease." The Lancet Infectious Diseases.

Accessibility

Free online on Lancet site.

Collection